Abiomed Inc.
Clinical trials sponsored by Abiomed Inc., explained in plain language.
A medical device company specializing in heart pumps, now part of Johnson & Johnson.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New study tracks impella use in heart attack shock patients
Knowledge-focused Recruiting nowThis study observes up to 350 patients who had a heart attack complicated by cardiogenic shock and received an Impella CP heart pump during artery-opening procedures. Researchers will track safety issues like major bleeding, limb problems, and kidney injury, as well as survival a…
Sponsor: Abiomed Inc. • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Heart pump data study aims to sharpen shock monitoring
Knowledge-focused Recruiting nowThis study gathers detailed, real-time information from the Impella heart pump and standard hospital monitors in 125 people with cardiogenic shock. The goal is to better understand how the pump and the body's vital signs work together. No new treatment is being tested; instead, r…
Sponsor: Abiomed Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists investigate what builds up on heart pumps after use
Knowledge-focused Recruiting nowThis study looks at heart pumps (Impella) after they have been used in patients with heart failure. Researchers will analyze deposits and biological material on the pumps and see if they relate to patient health or medical history. The goal is to learn more about how the pump int…
Sponsor: Abiomed Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC